Tallman MS - Search Results

1

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, Dugan K, Lum B, Chin DL, Dewald G, Paietta E, Bennett JM, Rowe JM. Greenberg PL, et al. Among authors: tallman ms. J Clin Oncol. 2004 Mar 15;22(6):1078-86. doi: 10.1200/JCO.2004.07.048. J Clin Oncol. 2004. PMID: 15020609 Free PMC article. Clinical Trial.

2

Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.

Tallman MS, Appelbaum FR, Amos D, Goldberg RS, Livingston RB, Mortimer J, Weiden PL, Thomas ED. Tallman MS, et al. J Clin Oncol. 1987 Jun;5(6):918-26. doi: 10.1200/JCO.1987.5.6.918. J Clin Oncol. 1987. PMID: 3585446

3

Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience.

Tallman MS, Gray R, Bennett JM, Variakojis D, Robert N, Wood WC, Rowe JM, Wiernik PH. Tallman MS, et al. J Clin Oncol. 1995 Jul;13(7):1557-63. doi: 10.1200/JCO.1995.13.7.1557. J Clin Oncol. 1995. PMID: 7602344 Clinical Trial.

4

Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.

Tallman MS, Hakimian D, Zanzig C, Hogan DK, Rademaker A, Rose E, Variakojis D. Tallman MS, et al. J Clin Oncol. 1995 Apr;13(4):983-8. doi: 10.1200/JCO.1995.13.4.983. J Clin Oncol. 1995. PMID: 7707127 Clinical Trial.

5

Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid.

Tallman MS, Rowe JM. Tallman MS, et al. Blood Rev. 1994 Jun;8(2):70-8. doi: 10.1016/s0268-960x(05)80010-4. Blood Rev. 1994. PMID: 7950477 Review. No abstract available.

6

Intensifying induction therapy in acute myeloid leukemia: has a new standard of care emerged?

Rowe JM, Tallman MS. Rowe JM, et al. Among authors: tallman ms. Blood. 1997 Sep 15;90(6):2121-6. Blood. 1997. PMID: 9310463 Free article. Review. No abstract available.

7

All-trans-retinoic acid in acute promyelocytic leukemia.

Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH. Tallman MS, et al. N Engl J Med. 1997 Oct 9;337(15):1021-8. doi: 10.1056/NEJM199710093371501. N Engl J Med. 1997. PMID: 9321529 Free article. Clinical Trial.

8

Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.

Bennett JM, Young ML, Andersen JW, Cassileth PA, Tallman MS, Paietta E, Wiernik PH, Rowe JM. Bennett JM, et al. Among authors: tallman ms. Cancer. 1997 Dec 1;80(11 Suppl):2205-9. Cancer. 1997. PMID: 9395035

9

Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group.

Paietta E, Andersen J, Yunis J, Rowe JM, Cassileth PA, Tallman MS, Bennett JM, Wiernik PH. Paietta E, et al. Among authors: tallman ms. Br J Haematol. 1998 Feb;100(2):265-72. doi: 10.1046/j.1365-2141.1998.00561.x. Br J Haematol. 1998. PMID: 9488612 Free article.

10

Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.

Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE. Ding W, et al. Among authors: tallman ms. Blood. 1998 Aug 15;92(4):1172-83. Blood. 1998. PMID: 9694705 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters